2005 Annual Meeting | Menopausal Neurology

Date Wednesday 04/13/05

Time 02:15 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Victor W. Henderson, MD, FAAN

Topic(s) Women's Issues

Learning Objectives Upon completion:
Participants should better understand the scientific and clinical relevance of ovarian hormones, menopause, and postmenopausal hormone therapy in Alzheimer's disease, stroke prevention, and the management of women with headache, sleep disorders, and epilepsy.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
02:15 PM - 02:45 PM		Alzheimer's Disease Victor W. Henderson, MD, FAAN
02:45 PM - 03:30 PM		Stroke Lawrence M. Brass, MD
03:30 PM - 03:45 PM		Break
03:45 PM - 04:30 PM		Migraine Headache Robert Cowan, MD, FAAN
04:30 PM - 05:15 PM		Sleep Disorders Christian Guilleminault, MD
05:15 PM - 06:00 PM		Epilepsy Andrew G. Herzog, MD, MSc, FAAN

Faculty Disclosures
Victor W. Henderson, MD, FAAN	Dr. Henderson has stock in Abbott, Amgen, Roche. The institution of Dr. Henderson has received research support from NIH. The institution of Dr. Henderson has received research support from Health IQ. Dr. Henderson has received personal compensation in the range of $500-$4,999 for serving as a External advisory committee member, Alzheimer's Disease Center with University of Kansas. Dr. Henderson has a non-compensated relationship as a adjunct (honorary) professor with Aarhus University that is relevant to AAN interests or activities.
Lawrence M. Brass, MD	No disclosure on file
Robert Cowan, MD, FAAN	Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for lundbeck. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biohavenn. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbviie. Dr. Cowan has stock in Percept. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received publishing royalties from a publication relating to health care.
Andrew G. Herzog, MD, MSc, FAAN	Dr. Herzog has nothing to disclose.
Christian Guilleminault, MD	No disclosure on file